Tg Therapeutics reported $-35818000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Amgen AMGN:US USD 2.14B 826M
Arrowhead Research ARWR:US USD -85511000 13.46M
Bayer BAYN:GR EUR 546M 844M
Biogen BIIB:US USD 1.13B 76.7M
Corcept Therapeutics CORT:US USD 34.61M 7.2M
Gilead Sciences GILD:US USD 1.79B 645M
Infinity Pharmaceuticals INFI:US USD -10717000 1.27M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Johnson & Johnson JNJ:US USD 4.46B 356M
Karyopharm Therapeutics KPTI:US USD -36324000 12.74M
Novartis NOVN:VX USD 1.57B 121M
Ptc Therapeutics PTCT:US USD -109315000 42.77M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Tg Therapeutics TGTX:US USD -35818000 4.69M
Verastem VSTM:US USD -18090000 3.86M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M